These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 4622109

  • 1. Functional evaluation of prolactin secretion: a guide to therapy.
    Friesen H, Guyda H, Hwang P, Tyson JE, Barbeau A.
    J Clin Invest; 1972 Mar; 51(3):706-9. PubMed ID: 4622109
    [Abstract] [Full Text] [Related]

  • 2. Levodopa suppression of prolactin in nonpuerperal galactorrhea.
    Malarkey WB, Jacobs LS, Daughaday WH.
    N Engl J Med; 1971 Nov 18; 285(21):1160-3. PubMed ID: 5107027
    [No Abstract] [Full Text] [Related]

  • 3. The effect of dexamethasone on TSH and prolactin secretion after TRH stimulation.
    Dussault JH.
    Can Med Assoc J; 1974 Dec 07; 111(11):1195-7. PubMed ID: 4215558
    [Abstract] [Full Text] [Related]

  • 4. Thyrotropin-releasing hormone is not the sole physiologic mediator of prolactin release during suckling.
    Gautvik KM, Tashjian AH, Kourides IA, Weintraub BD, Graeber CT, Maloof F, Suzuki K, Zuckerman JE.
    N Engl J Med; 1974 May 23; 290(21):1162-5. PubMed ID: 4207375
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of prolactin secretion and successful therapy of the Forbes-Albright syndrome with L-dopa.
    Turkington RW.
    J Clin Endocrinol Metab; 1972 Feb 23; 34(2):306-11. PubMed ID: 5062099
    [No Abstract] [Full Text] [Related]

  • 6. Hypothalamic pituitary disorders expressed by galactorrhea. A dynamic evaluation.
    Perez-Lopez FR.
    Obstet Gynecol; 1975 Nov 23; 46(5):621-6. PubMed ID: 812032
    [Abstract] [Full Text] [Related]

  • 7. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP, Jacobs LS, Hoffman W, Daughaday WH, Blizzard RM.
    J Clin Invest; 1972 Aug 23; 51(8):2143-50. PubMed ID: 4626583
    [Abstract] [Full Text] [Related]

  • 8. Measurement of pituitary hormones: clinical applications. 5. Prolactin.
    Donald RA, Espiner EA, Hodgkinson SC, Evans K.
    N Z Med J; 1976 Jun 23; 83(566):431-5. PubMed ID: 9604
    [Abstract] [Full Text] [Related]

  • 9. Effects on the pituitary-thyroid axis and prolactin secretion of single and repetitive oral doses of thyrotropin-releasing hormone (TRH).
    Rabello MM, Snyder PJ, Utiger RD.
    J Clin Endocrinol Metab; 1974 Sep 23; 39(3):571-8. PubMed ID: 4213076
    [No Abstract] [Full Text] [Related]

  • 10. Clinical and hormonal response to bromocriptin (CB-154) in the galactorrhea syndromes.
    Del Pozo E, Varga L, Wyss H, Tolis G, Friesen H, Wenner R, Vetter L, Uettwiler A.
    J Clin Endocrinol Metab; 1974 Jul 23; 39(1):18-26. PubMed ID: 4209685
    [No Abstract] [Full Text] [Related]

  • 11. Prolactin stimulation by thyrotropin-releasing hormone in a patient with isolated thyrotropin deficiency.
    Sachson R, Rosen SW, Cuatrecasas P, Roth J, Frantz AG.
    N Engl J Med; 1972 Nov 09; 287(19):972-3. PubMed ID: 4627862
    [No Abstract] [Full Text] [Related]

  • 12. [Effects of citicholine on pituitary gland function in normal subjects and in cases of idiopathic galactorrhea].
    de Rosa G, Gulino A, de Rosa E, Satta MA, Aiello A, Makhoul O, Pasargiklian E.
    Clin Ter; 1980 Aug 31; 94(4):407-14. PubMed ID: 6780259
    [No Abstract] [Full Text] [Related]

  • 13. Interrelationships in the regulation of TSH and prolactin secretion in man: effects of L-dopa, TRH and thyroid hormone in various combinations.
    Refetoff S, Fang VS, Rapoport B, Friesen HG.
    J Clin Endocrinol Metab; 1974 Mar 31; 38(3):450-7. PubMed ID: 4205563
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of prolactin secretion and successful therapy of the Forbes-Albright syndrome with L-dopa.
    Turkington RW, Gordon ES.
    J Lab Clin Med; 1971 Nov 31; 78(5):824-5. PubMed ID: 5166936
    [No Abstract] [Full Text] [Related]

  • 15. [TRH test II. Stimulation with thyrotropin releasing hormone(TRH) in patients with thyroid diseases].
    Dige-Petersen H, Hummer L.
    Ugeskr Laeger; 1974 Jun 17; 136(25):1356-60. PubMed ID: 4210164
    [No Abstract] [Full Text] [Related]

  • 16. Functional evaluation of prolactin secretion in patients with hypothalamic-pituitary disorders.
    Tolis G, Goldstein M, Friesen HG.
    J Clin Invest; 1973 Apr 17; 52(4):783-8. PubMed ID: 4632690
    [Abstract] [Full Text] [Related]

  • 17. [Effects of thyrotropin releasing hormone (TRH) in normal subjects and in patients with thyroid gland diseases].
    Lauridsen UB, Friis T, Kirkegaard C, Hansen JM, Siersbaek-Nielsen K.
    Ugeskr Laeger; 1974 Jun 17; 136(25):1360-4. PubMed ID: 4210165
    [No Abstract] [Full Text] [Related]

  • 18. Suppression of prolactin secretion by L-dopa in the stalk-sectioned rhesus monkey.
    Diefenbach WP, Carmel PW, Frantz AG, Ferin M.
    J Clin Endocrinol Metab; 1976 Sep 17; 43(3):638-42. PubMed ID: 821963
    [Abstract] [Full Text] [Related]

  • 19. Increased serum prolactin after administration of synthetic thyrotropin releasing hormone (TRH) in man.
    Jacobs LS, Snyder PJ, Wilber JF, Utiger RD, Daughaday WH.
    J Clin Endocrinol Metab; 1971 Dec 17; 33(6):996-8. PubMed ID: 5002718
    [No Abstract] [Full Text] [Related]

  • 20. Effects of biogenic amines and TRH on release of prolactin and TSH in the rat.
    Chen HJ, Meites J.
    Endocrinology; 1975 Jan 17; 96(1):10-4. PubMed ID: 803259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.